NORDITROPIN 5 MG

국가: 이스라엘

언어: 영어

출처: Ministry of Health

지금 구매하세요

공공 평가 보고서 공공 평가 보고서 (PAR)
18-08-2016

유효 성분:

SOMATROPIN

제공처:

NOVO NORDISK LTD., ISRAEL

ATC 코드:

H01AC01

약제 형태:

SOLUTION FOR INJECTION

구성:

SOMATROPIN 3.3 MG / 1 ML

관리 경로:

S.C

처방전 유형:

Required

Manufactured by:

NOVO NORDISK A/S, DENMARK

치료 그룹:

SOMATROPIN

치료 영역:

SOMATROPIN

치료 징후:

Children: Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome. Short stature in children with renal insufficiency. Growth disturbance (current height SDS < - 2.5 and parental adjusted height SDS < - 1) in short children born small for gestational age (SGA) with a birth weight and/or length below - 2 SD who failed to show catch-up growth (HV SDS < during the last year) by 4 years of age or later.Children with short stature associated with Noonan syndrome.Adults: Treatment of adults with Hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of G.H. deficiency. תוספת התוויה: 5/6/2019Indication:Children: Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome.Short stature in children with renal insufficiency.Growth disturbance (current height SDS < -2.5 and parental adjusted height SDS < -1) in short childre

승인 날짜:

2020-05-31

이 제품과 관련된 검색 알림